RaySearch Laboratories (Q4 Initial take): Another record quarter - Redeye
RaySearch delivered a strong Q4, with record sales above consensus estimates and record EBIT, also above consensus estimates. We expect the share to trade up by +15% for the day.
ANNONS
RaySearch delivered a strong Q4, with record sales above consensus estimates and record EBIT, also above consensus estimates. We expect the share to trade up by +15% for the day.
